Taipei, Taiwan

Hsuan-Pu Chen

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsuan-Pu Chen: Innovator in Genetic Engineering

Introduction

Hsuan-Pu Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of genetic engineering, particularly through his work with Chinese hamster ovary (CHO) cells. His innovative approach has opened new avenues for targeted gene integration, which is crucial for biotechnological advancements.

Latest Patents

Hsuan-Pu Chen holds a patent titled "Targeted integration sites in Chinese hamster ovary cell genome." This patent describes specific CHO genomic sites for the targeted insertion of exogenous genes. The sites are located within a sequence selected from SEQ ID NOs: 1-16. This innovation is pivotal for enhancing the efficiency of gene therapy and biopharmaceutical production.

Career Highlights

Hsuan-Pu Chen is affiliated with the Development Center for Biotechnology, where he applies his expertise in genetic engineering. His work has been instrumental in advancing biotechnological research and applications. With a focus on improving gene integration techniques, he continues to contribute to the scientific community.

Collaborations

Hsuan-Pu Chen collaborates with esteemed colleagues, including Hsueh-Lin Lu and Hsin-Lin Lu. These partnerships foster a collaborative environment that enhances research outcomes and drives innovation in biotechnology.

Conclusion

Hsuan-Pu Chen's contributions to genetic engineering exemplify the impact of innovative thinking in biotechnology. His patent on targeted integration sites represents a significant advancement in the field, showcasing his dedication to scientific progress.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…